Evidence map›Paper›PMID 26106154›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Tissue stiffness regulates serine/arginine-rich protein-mediated splicing of the extra domain B-fibronectin isoform in tumors.

Francois Bordeleau, Joseph P Califano, Yashira L Negrón Abril, Brooke N Mason, Danielle J LaValley, Sandra J Shin, Robert S Weiss, Cynthia A Reinhart-King

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Epitranscriptomic sculpting: the role of mMedical oncology (Northwood, London, England) · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Matrix stiffness-dependent regulation of immunomodulatory genes in human MSCs is associated with the lncRNA CYTOR.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Review
  15. Review
  16. Review
  17. Role of elastic fiber degradation in disease pathogenesis.Biochimica et biophysica acta. Molecular basis of disease · 2023
    Review
  18. Article
  19. Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Francois BordeleauDepartment of Biomedical Engineering, Cornell University, Ithaca, NY 14853;
Joseph P CalifanoDepartment of Biomedical Engineering, Cornell University, Ithaca, NY 14853;
Yashira L Negrón AbrilDepartment of Biomedical Sciences, Cornell University, Ithaca, NY 14853;
Brooke N MasonDepartment of Biomedical Engineering, Cornell University, Ithaca, NY 14853;
Danielle J LaValleyDepartment of Biomedical Engineering, Cornell University, Ithaca, NY 14853;
Sandra J ShinDepartment of Pathology and Laboratory Medicine, The New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY 10065.
Robert S WeissDepartment of Biomedical Sciences, Cornell University, Ithaca, NY 14853;
Cynthia A Reinhart-KingDepartment of Biomedical Engineering, Cornell University, Ithaca, NY 14853; cak57@cornell.edu.
Cornell University · US

Funding

CHEMISTRY OF BIOLOGICAL SYSTEMST32GM008500 · NIGMS · CORNELL UNIVERSITY ITHACA · PI LIN, HENING · 1996 to 2020
$5.4M
Succinylation and Malonylation as Novel Protein Modifications in CancerR01CA163255 · NCI · CORNELL UNIVERSITY · PI CERIONE, RICHARD A., LIN, HENING · 2011 to 2015
$2.9M
Mechanical Regulation of Tumor AngiogenesisR01HL127499 · NHLBI · VANDERBILT UNIVERSITY · PI REINHART-KING, CYNTHIA A. · 2015 to 2019
$2.4M
NCI NIH HHS R01 CA163255NHLBI NIH HHS 1R01HL127499NHLBI NIH HHS R01 HL127499NIGMS NIH HHS T32 GM008500
6 · The paper itself

Abstract

Alternative splicing of proteins gives rise to different isoforms that play a crucial role in regulating several cellular processes. Notably, splicing profiles are altered in several cancer types, and these profiles are believed to be involved in driving the oncogenic process. Although the importance of alternative splicing alterations occurring during cancer is increasingly appreciated, the underlying regulatory mechanisms remain poorly understood. In this study, we use both biochemical and physical tools coupled with engineered models, patient samples, and a murine model to investigate the role of the mechanical properties of the tumor microenvironment in regulating the production of the extra domain-B (EDB) splice variant of fibronectin (FN), a hallmark of tumor angiogenesis. Specifically, we show that the amount of EDB-FN produced by endothelial cells increases with matrix stiffness both in vitro and within mouse mammary tumors. Matrix stiffness regulates splicing through the activation of serine/arginine rich (SR) proteins, the splicing factors involved in the production of FN isoforms. Activation of the SR proteins by matrix stiffness and the subsequent production of EDB-FN are dependent on intracellular contractility and PI3K-AKT signaling. Notably, matrix stiffness-mediated splicing is not limited to EDB-FN, but also affects splicing in the production of PKC βII and the VEGF 165b splice variant. Together, these results demonstrate that the mechanical properties of the microenvironment regulate alternative splicing and establish a previously unidentified mechanism by which cells can adapt to their microenvironment.

Indexed as

Alternative SplicingAnimalsArginineBinding SitesBiomechanical PhenomenaBlotting, WesternCattleCells, CulturedEndothelial CellsExtracellular MatrixFibronectinsHumansMiceMicroscopy, ConfocalNeoplasmsNeovascularization, PathologicArginineFibronectinsPhosphatidylinositol 3-KinasesProtein IsoformsProto-Oncogene Proteins c-aktrho-Associated KinasesSerineVascular Endothelial Growth Factor Aalternative splicingangiogenesiscancer progressionextracellular matrixmatrix stiffness

Identifiers

PMID26106154
PMCPMC4500261
OpenAlexW1596656426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.